Russell Investments »

Celldex Therapeutics shares owned by Russell Investments

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Russell Investments from 13F filings

Historical chart of Russell Investments investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Russell Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Russell Investments

Quarter filed Position value Share count Share price at filing
2024-06-30 $150k 4.0k 37.01
2024-03-31 $1.2k 29 41.97

More positions owned by Russell Investments

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Apple Common Stock (AAPL)
Amazon Common Stock (AMZN)
Meta Platforms Common Stock (META)
Alphabet Common Stock (GOOGL)
Alphabet Common Stock (GOOG)
Taiwan Semiconductor Manufacturing Common Stock (TSM)
Mastercard Incorporated Common Stock (MA)
Eli Lilly And Company Common Stock (LLY)
Unitedhealth Group Common Stock (UNH)
Welltower Common Stock (WELL)
Prologis Common Stock (PLD)
Digital Realty Trust Common Stock (DLR)
J P Morgan Chase And Common Stock (JPM)

View all positions for Russell Investments

Top funds holding Celldex Therapeutics

BlackRock
BlackRock
Vanguard Group
Kynam Capital Management
Eventide Asset Management
Bellevue Group
T. Rowe Price Associates
State Street Corporation
Woodline Partners
T. Rowe Price Investment Management
Point72 Asset Management
Commodore Capital
Geode Capital Management
Rock Springs Capital Management
Jennison Associates

View all funds holding Celldex Therapeutics